Literature DB >> 1530647

Cloning and functional characterization of a human A1 adenosine receptor.

F Libert1, J Van Sande, A Lefort, A Czernilofsky, J E Dumont, G Vassart, H A Ensinger, K D Mendla.   

Abstract

A human brain hippocampus cDNA library was screened by hybridization with a dog A1 adenosine receptor cDNA probe. Sequencing of the resulting clones identified a 978 residue open reading frame encoding a 326 amino acid polypeptide showing 95.7% similarity with the dog A1 adenosine receptor. Individual clones of stably transfected CHO cells expressing the human A1 receptor were obtained and tested for their response to the A1 agonist CPA [N6-cyclopentyladenosine] in the presence of forskolin. One clone was further characterized with respect to membrane binding of various adenosine agonists and antagonists. The rank order of affinities observed was typical of an A1 adenosine receptor. A Kd value of 2.28 nM was determined using [3H]DPCPX [dipropylcyclopentyl-xanthine], an A1 selective antagonist.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530647     DOI: 10.1016/0006-291x(92)91285-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Positive control of proliferation by the cyclic AMP cascade: an oncogenic mechanism of hyper-functional adenoma.

Authors:  C Ledent; J Parma; I Pirson; M Taton; P Roger; C Maenhaut; J Van Saude; V Pohl; F Lamy; M Parmentier
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

2.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 3.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

4.  The human A1 adenosine receptor: ligand binding properties, sites of somatic expression and chromosomal localization.

Authors:  S A Rivkees; M E Lasbury; G S Stiles; O Henegariu; C Curtis; G Vance
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

5.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion.

Authors:  D L Hancock; I M Coupar
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Adenosine A1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.

Authors:  S P Alexander; A Losinski; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands.

Authors:  Jillian G Baker; Richard Middleton; Luke Adams; Lauren T May; Stephen J Briddon; Barrie Kellam; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2010-01-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.